Loading clinical trials...
Loading clinical trials...
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
NCT00935090 · Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, and more
NCT01137825 · Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, and more
NCT07319897 · Multiple Myeloma, Multiple Myeloma and Malignant Plasma Cell Neoplasms, and more
NCT00611351 · Graft Versus Host Disease, Leukemia, and more
NCT00049673 · Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions